1. Organization Of Intensive Care Service For Patients With Covid-19 During Pandemia (Review)
Downloads
Abstract
Since the beginning of the new coronavirus infection pandemia over 57.9 million people have been infected and over 1.3 million have died. The world statistics on COVID-19 rates Kazakhstan as 49 with revealed cases of COVID-19 and 53 with deaths cases. In 80% of patients with COVID-19, COVID-19 have mild or moderate disease, about 15% have severe disease requires oxygen support, and 5% have a critical illness requires stay in intensive care units. The average duration of ICU stay is 10.8 days. In 22.7% of patients, ICU length of stay is over 30 days. The mortality rate of patients in intensive care units was 40-61% during the first wave, but in most affected regions it was as high as 90%. In order to improve the results of intensive care, a team-based way introduced in many hospitals. These teams do most labor-consuming and potentially dangerous manipulations. This approach requires a sufficient number of engaged and well-trained staff. In in an acute shortage of ICU staff, some actions assumed to train medical personnel of other specialties to become doctors and nurses in intensive care units. Short and superficial courses, designed to prepare the maxi-mum number of intensive care specialists in the shortest time, as a rule, leads to a deterioration in the quality of the provided intensive care and does not improve results and mortality.
Keywords
COVID-19 pandemia, critical care
References
- Burke RM, Midgley CM, Dratch A, Fenstersheib M, Haupt T, HolshueM, et al. Active monitoring of per-sons exposed to patients with confirmed COVID-19 — United States, January–February
- Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. JAMA.
- Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Mer-edith HR, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med.
- Liu Y, Yan LM, Wan L, Xiang TX, Le A, Liu JM, et al. Vi-ral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis.
- Yu P, Zhu J, Zhang Z, Han Y, Huang L. A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period. J Infect Dis.
- Huang R, Xia J, Chen Y, Shan C, Wu C. A family clus-ter of SARS-CoV-2 infection involving 11 patients in Nanjing, China. Lancet Infect Dis. 2020;20(5):534-5. Epub 2020/03/03
- Pan X, Chen D, Xia Y, Wu X, Li T, Ou X, et al. Asymp-tomatic cases in a family cluster with SARS-CoV-2 infection. Lancet Infect Dis. 2020;20(4):410-1
- Tong ZD, Tang A, Li KF, Li P, Wang HL, Yi JP, et al. Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China,
- Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital surveillances: the epidemi-ological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) – China. China CDC Weekly. 2020;2(8):113-22
- Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, et al. Prevalence, Severity and Mortality Associated with COPD and Smoking in Patients with COVID-19: A Rapid Sys-tematic Review and Meta-Analysis. PLoS One. 2020;15(5):e0233147. Epub2020/05/12
- Табакокурение и COVID-19. Заявление ВОЗ от 11 мая 2020 г. Женева: Всемирная организация здравоохранения; 2020 (https://www.who.int/ru/ news-room/detail/11-05-2020-who-statement-tobacco-use-and-covid-19, по состоянию на 29 мая 2020 г.)
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. Epub 2020/01/28
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpa-tients with COVID-19 in Wuhan, China: a retrospec-tive cohort study. Lancet. 2020;395(10229):1054-62. Epub 2020/03/15
- Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Co-vid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med 2020;382:2012-22
- Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics and Outcomes of 1591 Patients In-fected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA 2020; doi:10.1001/jama.2020.5394
- Yang X, Yu Y, Xu J, et al. Clinical course and out-comes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, ret-rospective, observational study. Lancet Respir Med 2020;8:475-81
- Karagiannidis C, Mostert C,Hentschker C, et al. Case characteristics,resource use, and outcomes of 10,021patients with COVID-19 admitted to 920Ger-man hospitals: an observational study.Lancet Respir Med.
- Mitra AR, Fergusson NA, Lloyd-Smith E,et al. Baseline characteristics andoutcomes of patients with COVID-19admitted to intensive care units inVancouver, Can-ada: a case series.CMAJ.2020;192(26):E694-E701
- Опыт государств в борьбе с пандемией COVID-19. Сборник страновых кейсов. Счетная палата Рос-сийской Федерации. 2020
- Gilardino R.E. Does “Flattening the Curve” Affect Critical Care Services Delivery for COVID-19? A Global Health Perspective. International Journal of Health Policy and Management, 2020, 9(12), 503–507. David
- M. Yang, H. Dong, Zh. Lu Role of anaesthesiolo-gists during the COVID-19 outbreak in China. Br J Anaesth. 2020 Jun; 124(6): 666–669
- L. Miller, E. Luković, G. Wagener Guiding airway management and personal protective equipment for COVID-19 intubation teams. BJA 2020: Volume 125, ISSUE 3, e288-e290
- Sorbello, Massimiliano MD; Morello, Gianluigi MD; Pintaudi, Sergio MD; Cataldo, Rita MD COVID-19: Intubation Kit, Intubation Team, or Intubation Spots?, Anesthesia & Analgesia: August 2020 - Volume 131 -Issue 2 - p e128-e130
- Blumenthal et al, Covid-19 – Implications for the Health Care System. N Engl J Med; 2020:383;15; p 1483-1488 WITH COVID-19 DURING PANDEMIA (REVIEW)